Brief Tailored Smoking Cessation Counseling in a Lung Cancer Screening Population is Feasible: A Pilot Randomized Controlled Trial

被引:29
|
作者
Marshall, Henry M. [1 ]
Courtney, Deborah A. [1 ]
Passmore, Linda H. [1 ]
McCaul, Elizabeth M. [1 ]
Yang, Ian A. [1 ]
Bowman, Rayleen V. [1 ]
Fong, Kwun M. [1 ]
机构
[1] Univ Queensland, Thorac Res Ctr, Prince Charles Hosp, Rode Rd, Brisbane, Qld 4032, Australia
基金
英国医学研究理事会;
关键词
PRIMARY-CARE PROVIDERS; COMPUTED-TOMOGRAPHY; INTERVENTION; ATTITUDES; PARTICIPANTS; PERCEPTIONS; DEPENDENCE; BELIEFS;
D O I
10.1093/ntr/ntw010
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Maximizing smoking abstinence in lung cancer screening participants is important to reduce individual risk of disease and improve screening cost-effectiveness; however, the optimal strategy remains undefined. We hypothesized that a single session of tailored face-to-face counseling on the day of screening CT scan, coupled with audio and printed cessation information would be feasible to deliver in a CT screening trial. Methods: We randomized volunteer smokers in the Queensland Lung Cancer Screening Study to intervention (counseling session, audio quit materials, printed quit materials, Quitline contact details) or control group (printed quit materials, Quitline contact details). Participants self-reported point prevalence quit rates at 1 year. Results: Fifty-five smokers were enrolled; 28 randomized to intervention and 27 controls. Median cigarette consumption was 25/day; 54/55 smoked at least 15 cigarettes per day. Median smoking duration was 46 years. Median Fagerstrom dependence score was 6. In total 58% did not report any quit attempt in the prior 12 months. Mean duration of counseling was 26.5 minutes. After 1 year, four participants (14.3%) in the intervention group and five participants (18.5%) in the control group had quit (P = .74). Combined annual point prevalence quit rate was 16.4%. Conclusions: Although feasible to deliver a single session of tailored counseling on the day of screening this intervention had no discernible impact on cessation over and above printed materials and Quitline access. As participants exhibited hardcore smoking characteristics, more intensive strategies, in larger cohorts, should be explored. Implications: The optimal smoking cessation strategy within a lung cancer screening program is not known. This study demonstrates that a single session of counseling can be feasibly delivered on the day of screening but may not have been intensive enough for long-term, hard-core smokers.
引用
收藏
页码:1665 / 1669
页数:5
相关论文
共 50 条
  • [1] A Pilot Randomized Controlled Trial of a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients
    Aimer, Pip
    Treharne, Gareth
    Stebbings, Simon
    Frampton, Christopher
    Cameron, Vicky
    Kirby, Sandra
    Stamp, Lisa K.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1035 - S1035
  • [2] Proactive Telephone Smoking Cessation Counseling Tailored to Parents: Results of a Randomized Controlled Effectiveness Trial
    Scheffers-van Schayck, Tessa
    Otten, Roy
    Engels, Rutger C. M. E.
    Kleinjan, Marloes
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (15)
  • [3] Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot Trial
    Bernard, Paquito
    Ninot, Gregory
    Cyprien, Fabienne
    Courtet, Philippe
    Guillaume, Sebastien
    Georgescu, Vera
    Picot, Marie-Christine
    Taylor, Adrian
    Quantin, Xavier
    JOURNAL OF DUAL DIAGNOSIS, 2015, 11 (3-4) : 205 - 216
  • [4] A Randomized Controlled Trial of a Digital Lung Health Intervention to Facilitate Smoking Cessation and Lung Cancer Screening
    Cooley, M.
    Xiong, N.
    Mazzola, E.
    Nayak, M.
    DeMarco, R.
    Borondy-Kitts, A.
    Blazey, M.
    Healey, M.
    Yang, C. -F. J.
    Castaldi, P.
    Kim, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S48 - S49
  • [5] The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: A randomised controlled trial
    van der Aalst, Carlijn M.
    de Koning, Harry J.
    van den Bergh, Karien A. M.
    Willemsen, Marc C.
    van Klaveren, Rob J.
    LUNG CANCER, 2012, 76 (02) : 204 - 210
  • [6] EXERCISE AND COUNSELING FOR SMOKING CESSATION IN SMOKERS WITH CURRENT DEPRESSIVE SYMPTOMS: A RANDOMIZED CONTROLLED PILOT TRIAL
    Bernard, Paquito
    Ninot, Gregory
    Cyprien, Fabienne
    Courtet, Philippe
    Guillaume, Sebastien
    Georgescu, Vera
    Picot, Marie-Christine
    Taylor, Adrian
    Quantin, Xavier
    ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S65 - S65
  • [7] A RANDOMIZED PILOT STUDY OF A SMOKING CESSATION INTERVENTION IN THE LUNG CANCER SCREENING SETTING
    Taylor, Kathryn
    Hagerman, Charlotte
    Bellini, Paula
    Regis, Shawn
    McKee, Andrea
    Ramsaier, Michael
    Harper, Harry
    Kramer, Jenna
    Anderson, Eric
    Stanton, Cassandra A.
    Abrams, David B.
    Zinar, Riley
    Leigh, Daniel
    ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S101 - S101
  • [8] Brief mindfulness training for smoking cessation in Chinese women in workplaces: A pilot randomized controlled trial
    Weng, Xue
    Luk, Tzu Tsun
    Lau, Oi Sze
    Suen, Yi Nam
    Lee, Jung Jae
    Li, William Ho-cheung
    Kwok, Jojo Yan Yan
    Lam, Tai Hing
    Wang, Man Ping
    ADDICTIVE BEHAVIORS, 2021, 113
  • [9] A Randomized Controlled Study of Integrated Smoking Cessation in a Lung Cancer Screening Program
    Tremblay, Alain
    Taghizadeh, Niloofar
    Huang, Jane
    Kasowski, Debra
    MacEachern, Paul
    Burrowes, Paul
    Graham, Andrew J.
    Dickinson, James A.
    Lam, Stephen C.
    Yang, Huiming
    Koetzler, Rommy
    Tammemagi, Martin
    Taylor, Kathryn
    Bedard, Eric L. R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (09) : 1528 - 1537
  • [10] Smoking Cessation Interventions in the Lung Cancer Screening Setting A Randomized Clinical Trial
    Cinciripini, Paul M.
    Minnix, Jennifer A.
    Kypriotakis, George
    Erasmus, Jeremy
    Beneventi, Diane
    Karam-Hage, Maher
    Carpenter, Kelly
    Volk, Robert J.
    Carter, Brett
    Godoy, Myrna C. B.
    Strange, Chad
    Shih, Ya-Chen Tina
    Cui, Yong
    Green, Charles E.
    Robinson, Jason D.
    JAMA INTERNAL MEDICINE, 2025, 185 (03) : 284 - 291